Crucial roles of MZF-1 in the transcriptional regulation of apomorphine-induced modulation of FGF-2 expression in astrocytic cultures

Journal of Neurochemistry

Volumn 108, Issue 4, 2009, Pages 952-961

  Luo, Xiaoying ^a,b   Zhang, Xinhua ^a,b   Shao, Wei ^a   Yin, Yanqin ^a   Zhou, Jiawei ^a,b  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Apomorphine; Astrocyte; FGF 2 promoter; Gene regulation; MZF 1

Indexed keywords

APOMORPHINE; CYCLIC AMP; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; FIBROBLAST GROWTH FACTOR 2; MYELOID ZINC FINGER PROTEIN 1; PROTEIN KINASE C; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; CORPUS STRIATUM; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; TRANSCRIPTION REGULATION;

ANIMALS; ANIMALS, NEWBORN; APOMORPHINE; ASTROCYTES; CELLS, CULTURED; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NEURONS; PARKINSON DISEASE; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTIONAL ACTIVATION;

PARKINSONIA;

EID: 58549113002     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05845.x     Document Type: Article

References (29)

1. Abbott N. J., Ronnback L. Hansson E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41 53.
2. Bal A., Bachelot T., Savasta M., Manier M., Verna J. M., Benabid A. L. Feuerstein C. (1994) Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies. Brain Res. Mol. Brain Res. 23, 204 212.
3. Beranek M., Tschoplova S., Kankova K., Kuhrova V. Vacha J. (2003) Genetic variation in the promoter region of the basic fibroblast growth factor gene. Hum. Immunol. 64, 374 377.
4. Black S. M., DeVol J. M. Wedgwood S. (2008) Regulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generation. Am. J. Physiol. Cell Physiol. 294, C345 C354.
5. Chang P. Y., Lu S. C., Lee C. M. et al. (2008) Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ. Res., 102, 933 941.
6. Detillieux K. A., Meyers A. F., Meij J. T. Cattini P. A. (1998) An A/G-rich motif in the rat fibroblast growth factor-2 gene confers enhancer activity on a heterologous promoter in neonatal rat cardiac myocytes. Mol. Cell. Biochem. 188, 169 176.
7. Felts P. A. Smith K. J. (1996) Blood-brain barrier permeability in astrocyte-free regions of the central nervous system remyelinated by Schwann cells. Neuroscience 75, 643 655.
8. Grasby P. M., Friston K. J., Bench C. J., Cowen P. J., Frith C. D., Liddle P. F., Frackowiak R. S. Dolan R. J. (1993) The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers. Psychol. Med. 23, 605 612.
9. Holley J. E., Gveric D., Newcombe J., Cuzner M. L. Gutowski N. J. (2003) Astrocyte characterization in the multiple sclerosis glial scar. Neuropathol. Appl. Neurobiol. 29, 434 444.
10. Hu Y., Lund I. V., Gravielle M. C., Farb D. H., Brooks-Kayal A. R. Russek S. J. (2008) Surface expression of GABAA receptors is transcriptionally controlled by the interplay of cAMP-response element-binding protein and its binding partner inducible cAMP early repressor. J. Biol. Chem., 283, 9328 9340.
11. Jankovic J. (2008) Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368 376.
12. Jimenez S. K., Sheikh F., Jin Y., Detillieux K. A., Dhaliwal J., Kardami E. Cattini P. A. (2004) Transcriptional regulation of FGF-2 gene expression in cardiac myocytes. Cardiovasc. Res. 62, 548 557.
13. Kelly M. A., Rubinstein M., Asa S. L. et al. (1997) Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice. Neuron 19, 103 113.
14. Kyriazis M. (2003) Neuroprotective, anti-apoptotic effects of apomorphine. J. Anti Aging Med. 6, 21 28.
15. Le Mee S., Fromigue O. Marie P. J. (2005) Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp. Cell Res., 302, 129 142.
16. Li A., Guo H., Luo X., Sheng J., Yang S., Yin Y., Zhou J. Zhou J. (2006) Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons. FASEB J. 20, 1263 1265.
17. Meisinger C. Grothe C. (1997) Differential expression of FGF-2 isoforms in the rat adrenal medulla during postnatal development in vivo. Brain Res. 757, 291 294.
18. Menet V., Gimenez y Ribotta M., Chauvet N., Drian M. J., Lannoy J., Colucci-Guyon E. Privat A. (2001) Inactivation of the glial fibrillary acidic protein gene, but not that of vimentin, improves neuronal survival and neurite growth by modifying adhesion molecule expression. J. Neurosci. 21, 6147 6158.
19. Miyazaki I., Asanuma M., Diaz-Corrales F. J., Miyoshi K. Ogawa N. (2004) Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res. 1029, 120 123.
20. Moffett J., Kratz E., Myers J., Stachowiak E. K., Florkiewicz R. Z. Stachowiak M. K. (1998) Transcriptional regulation of fibroblast growth factor-2 expression in human astrocytes: implications for cell plasticity. Mol. Biol. Cell, 9, 2269 2285.
21. Nakazawa F., Nagai H., Shin M. Sheng G. (2006) Negative regulation of primitive hematopoiesis by the FGF signaling pathway. Blood 108, 3335 3343.
22. Obeso J. A., Rodriguez-Oroz M. C., Benitez-Temino B., Blesa F. J., Guridi J., Marin C. Rodriguez M. (2008) Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease. Mov. Disord. 23 (Suppl 3 S548 S559.
23. Ohta M., Mizuta I., Ohta K., Nishimura M., Mizuta E., Hayashi K. Kuno S. (2000) Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes. Biochem. Biophys. Res. Commun. 272, 18 22.
24. Petrovic M. G., Krkovic M., Osredkar J., Hawlina M. Petrovic D. (2008) Polymorphisms in the promoter region of the basic fibroblast growth factor gene and proliferative diabetic retinopathy in Caucasians with type 2 diabetes. Clin. Exp. Ophthalmol. 36, 168 172.
25. Santello M. Volterra A. (2008) Synaptic modulation by astrocytes via Ca(2+)-dependent glutamate release. Neuroscience [Epub ahead of print] doi :.
26. Tien L. T., Park Y., Fan L. W., Ma T., Loh H. H. Ho I. K. (2003) Increased dopamine D2 receptor binding and enhanced apomorphine-induced locomotor activity in mu-opioid receptor knockout mice. Brain Res. Bull. 61, 109 115.
27. Timmer M., Cesnulevicius K., Winkler C., Kolb J., Lipokatic-Takacs E., Jungnickel J. Grothe C. (2007) Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion. J. Neurosci. 27, 459 471.
28. Vila M., Jackson-Lewis V., Guegan C., Wu D. C., Teismann P., Choi D. K., Tieu K. Przedborski S. (2001) The role of glial cells in Parkinson's disease. Curr. Opin. Neurol. 14, 483 489.
29. Zanassi P., Paolillo M., Montecucco A., Avvedimento E. V. Schinelli S. (1999) Pharmacological and molecular evidence for dopamine D(1) receptor expression by striatal astrocytes in culture. J. Neurosci. Res. 58, 544 552.